Chemotherapy of enterobiasis (oxyuriasis)
| Autor: | Vassil St. Georgiev |
|---|---|
| Rok vydání: | 2001 |
| Předmět: |
Male
medicine.medical_specialty Mebendazole Population Irritability Albendazole Pruritus Ani Disease Transmission Infectious medicine Animals Humans Pharmacology (medical) Enterobius Child education Pharmacology education.field_of_study Granuloma business.industry Antinematodal Agents Enterobiasis General Medicine Dermatology Surgery Eczematous dermatitis Female Genital Diseases Male medicine.symptom business Genital Diseases Female medicine.drug Oxyuriasis |
| Zdroj: | Expert Opinion on Pharmacotherapy. 2:267-275 |
| ISSN: | 1744-7666 1465-6566 |
| DOI: | 10.1517/14656566.2.2.267 |
| Popis: | Enterobius vermicularis (syn. Oxyurus vermicularis), also known as pinworm or seatworm, is the causative agent of human enterobiasis (oxyuriasis). The disease is more prevalent in temperate regions and is facilitated by factors such as overcrowding in schools and family groupings, as well as inadequate personal and community hygiene. Although the infection is more likely to occur in lower socioeconomic groups, enterobiasis has been reported to affect virtually every level of the general population and especially children. In the great majority of cases, enterobiasis is asymptomatic. One common symptom is intense pruritus ani that in some patients can lead to insomnia, restlessness and irritability. Scratching may cause skin irritation, and in more serious cases, eczematous dermatitis, haemorrhage or secondary bacterial infections. Ectopic migration of E. vermicularis often results in pinworm infestation of the female genital tract often causing granulomas of the uterus, ovary and the fallopian tubes and pelvic peritoneum. Anthelmintic therapies for enterobiasis are successful and include mebendazole, albendazole and pyrantel pamoate. Mass medication of affected groups reduced symptoms rapidly, progressively and in a cost-effective way. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|